EPS for Quidel Corporation (QDEL) Expected At $0.41

October 14, 2018 - By Nellie Frank

Investors sentiment decreased to 1.31 in Q2 2018. Its down 0.14, from 1.45 in 2018Q1. It fall, as 16 investors sold Quidel Corporation shares while 49 reduced holdings. 40 funds opened positions while 45 raised stakes. 34.22 million shares or 3.40% more from 33.10 million shares in 2018Q1 were reported.
Sg Americas Secs Llc has 36,430 shares for 0.02% of their portfolio. Goldman Sachs Grp Inc holds 0% of its portfolio in Quidel Corporation (NASDAQ:QDEL) for 63,698 shares. California State Teachers Retirement System reported 50,189 shares. State Street Corporation invested in 0% or 726,889 shares. Pitcairn stated it has 8,247 shares or 0.06% of all its holdings. Vanguard Gru Inc holds 0.01% or 2.78M shares in its portfolio. First Mercantile Trust holds 2,590 shares. Massachusetts Financial Svcs Ma holds 0.01% or 333,652 shares. Los Angeles Capital Mngmt Equity Research stated it has 0% of its portfolio in Quidel Corporation (NASDAQ:QDEL). Eagle Boston Mgmt Inc stated it has 1.79% of its portfolio in Quidel Corporation (NASDAQ:QDEL). Barclays Public Lc reported 2,401 shares or 0% of all its holdings. Manufacturers Life Communication The holds 0% or 24,161 shares in its portfolio. Financial Bank Of America De stated it has 59,783 shares or 0% of all its holdings. Piedmont Inv Advsr Lc owns 569 shares. Moreover, Pnc Financial Ser Group has 0% invested in Quidel Corporation (NASDAQ:QDEL) for 526 shares.

Since April 26, 2018, it had 0 insider buys, and 16 selling transactions for $21.46 million activity. $165,392 worth of Quidel Corporation (NASDAQ:QDEL) was sold by Kroll Werner on Tuesday, June 12. The insider STEWARD RANDALL J sold 38,162 shares worth $2.68M. POLAN MARY LAKE PH D had sold 16,002 shares worth $1.12M. Bujarski Robert Joseph also sold $2.70M worth of Quidel Corporation (NASDAQ:QDEL) on Friday, August 17. 17,596 Quidel Corporation (NASDAQ:QDEL) shares with value of $1.24 million were sold by Abney Michael Donald Jr.. Another trade for 5,000 shares valued at $375,039 was made by BUECHLER KENNETH F on Thursday, August 30.

Analysts expect Quidel Corporation (NASDAQ:QDEL) to report $0.41 EPS on November, 7.They anticipate $0.57 EPS change or 356.25 % from last quarter’s $-0.16 EPS. QDEL’s profit would be $16.01 million giving it 38.84 P/E if the $0.41 EPS is correct. After having $0.29 EPS previously, Quidel Corporation’s analysts see 41.38 % EPS growth. The stock increased 1.00% or $0.63 during the last trading session, reaching $63.7. About 213,376 shares traded. Quidel Corporation (NASDAQ:QDEL) has risen 98.40% since October 14, 2017 and is uptrending. It has outperformed by 82.78% the S&P500.

Quidel Corporation (NASDAQ:QDEL) Ratings Coverage

Among 2 analysts covering Quidel (NASDAQ:QDEL), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Quidel had 3 analyst reports since August 6, 2018 according to SRatingsIntel. The stock of Quidel Corporation (NASDAQ:QDEL) has “Buy” rating given on Monday, September 10 by Canaccord Genuity. The company was maintained on Monday, August 6 by Barclays Capital. The company was maintained on Tuesday, August 14 by Canaccord Genuity.

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications primarily in infectious diseases, POC women??s and general health, and gastrointestinal diseases. The company has market cap of $2.49 billion. The firm offers Sofia influenza A+B and QuickVue influenza tests to detect viral antigens of influenza type A and B; Sofia strep A fluorescent immunoassay and QuickVue Strep A tests to detect group A Streptococcal antigen from throat swabs; and Sofia Respiratory Syncytial Virus , QuickVue RSV, and Quidel Molecular RSV + human metapneumovirus tests for respiratory syncytial virus. It has a 111.17 P/E ratio. It also provides various products to detect various herpes simplex virus (HSV) and herpes family viruses; H&V-Mix to isolate HSV, VZV, and Cytomegalovirus; R-Mix to detect Influenza A and B, RSV, Adenovirus, and Parainfluenza types 1, 2, and 3; Sofia S.

More news for Quidel Corporation (NASDAQ:QDEL) were recently published by: Seekingalpha.com, which released: “Canaccord bullish on medical diagnostic firms” on September 14, 2018. Nasdaq.com‘s article titled: “Research Report Identifies Keysight Technologies, Quidel, LKQ, Louisiana-Pacific, Air Transport Services Group, and …” and published on October 09, 2018 is yet another important article.

Quidel Corporation (NASDAQ:QDEL) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

>